Following tumor-specific Cat-B cleavage, NanoTAC induces potent pyroptosis through PDT integrated with HK2 proteolysis, leading to complete regression of refractory TNBC and suppression of recurrence and metastasis. The gene discussed is TYRP1; the disease is neoplasm.